Structure and function of the skeletal muscle extracellular matrix

Muscle and Nerve

Volumn 44, Issue 3, 2011, Pages 318-331

  Gillies, Allison R ^a   Lieber, Richard L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomechanics; Collagen; Extracellular matrix; Fibrosis; Skeletal muscle

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 12; COLLAGEN TYPE 13; COLLAGEN TYPE 14; COLLAGEN TYPE 15; COLLAGEN TYPE 18; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; COLLAGEN TYPE 7; COLLAGEN TYPE 8; COLLAGEN TYPE 9; COLLAGENASE 3; CYSTEINE; CYTOKINE; DECORIN; GELATINASE A; GELATINASE B; OSTEOPONTIN; PROTEOGLYCAN; TENASCIN; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNINDEXED DRUG;

ENDOMYSIUM; EPIMYSIUM; EXTENSOR DIGITORUM LONGUS MUSCLE; EXTRACELLULAR MATRIX; HUMAN; MUSCLE CONTRACTION; MUSCLE EXAMINATION; MUSCLE FUNCTION; MUSCLE LENGTH; NONHUMAN; PERIMYSIUM; PRIORITY JOURNAL; REVIEW; SCANNING ELECTRON MICROSCOPY; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOMECHANICS; COLLAGEN; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; MICE; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; MUSCLE, SKELETAL; PROTEOGLYCANS; RABBITS;

EID: 80052041196     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22094     Document Type: Review

References (137)

1. Eisenberg BR. Quantitative ultrastructure of mammalian skeletal muscle. In: Peachey LD, Adrian RH, Geiger SR, editors. Skeletal muscle. Baltimore, MD: American Physiological Society; 1983. p 73-112.
2. Trotter JA, Purslow PP. Functional morphology of the endomysium in series fibered muscles. J Morphol 1992;212:109-122.
3. Purslow PP, Trotter JA. The morphology and mechanical properties of endomysium in series-fibred muscles: variations with muscle length. J Muscle Res Cell Motil 1994;15:299-308.
4. Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Jarvinen M. Organization and distribution of intramuscular connective tissue in normal and immobilized skeletal muscles. An immunohistochemical, polarization and scanning electron microscopic study. J Muscle Res Cell Motil 2002;23:245-254.
5. Borg TK, Caulfield JB. Morphology of connective tissue in skeletal muscle. Tissue Cell 1980;12:197-207.
6. Rowe RW. Morphology of perimysial and endomysial connective tissue in skeletal muscle. Tissue Cell 1981;13:681-690.
7. Passerieux E, Rossignol R, Chopard A, Carnino A, Marini JF, Letel-lier T, et al. Structural organization of the perimysium in bovine skeletal muscle: junctional plates and associated intracellular subdo-mains. J Struct Biol 2006;154:206-216.
8. Young M, Paul A, Rodda J, Duxson M, Sheard P. Examination of intrafascicular muscle fiber terminations: implications for tension delivery in series-fibered muscles. J Morphol 2000;245:130-145.
9. Schiaffino S, Reggiani C. Myosin isoforms in mammalian skeletal muscle. J Appl Physiol 1994;77:493-501.
10. Hanley PJ, Young AA, LeGrice IJ, Edgar SG, Loiselle DS. 3-Dimen-sional configuration of perimysial collagen fibres in rat cardiac muscle at resting and extended sarcomere lengths. J Physiol 1999;517: 831-837.
11. Nakamura YN, Iwamoto H, Yamaguchi T, Ono Y, Nakanishi Y, Tabata S, et al. Three-dimensional reconstruction of intramuscular collagen networks of bovine muscle: a demonstration by an immu-nohistochemical/confocal laser-scanning microscopic method. Anim Sci J 2007;78:445-447.
12. Butler DL, Grood ES, Noyes FR, Zernicke RF. Biomechanics of ligaments and tendons. Exerc Sport Sci Rev 1978;6:125-181.
13. Gao Y, Kostrominova TY, Faulkner JA, Wineman AS. Age-related changes in the mechanical properties of the epimysium in skeletal muscles of rats. J Biomech 2008;41:465-469.
14. Gao Y, Waas AM, Faulkner JA, Kostrominova TY, Wineman AS. Micromechanical modeling of the epimysium of the skeletal muscles. J Biomech 2008;41:1-10.
15. Huijing PA. Muscle as a collagen fiber reinforced composite: a review of force transmission in muscle and whole limb. J Biomech 1999;32:329-345.
16. Passerieux E, Rossignol R, Letellier T, Delage JP. Physical continuity of the perimysium from myofibers to tendons: involvement in lateral force transmission in skeletal muscle. J Struct Biol 2007;159: 19-28.
17. Ounjian M, Roy RR, Eldred E, Garfinkel A, Payne JR, Armstrong A, et al. Physiological and developmental implications of motor unit anatomy. J Neurobiol 1991;22:547-559.
18. Patel TJ, Lieber RL. Force transmission in skeletal muscle: from actomyosin to external tendons. Exerc Sport Sci Rev 1997;25:321-363.
19. Bendall JR. Elastin content of various muscles of beef animals. J Sci Food Agric 1967;18:553-558.
20. Dransfield E. Intramuscular composition and texture of beef muscles. J Sci Food Agr 1977;28:833-842.
21. Gelse K, Poschl E, Aigner T. Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 2003;55:1531-1546.
22. Halfter W, Dong S, Schurer B, Cole GJ. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 1998; 273:25404-25412.
23. Listrat A, Lethias C, Hocquette JF, Renand G, Menissier F, Geay Y, et al. Age-related changes and location of types I, III, XII and XIV collagen during development of skeletal muscles from genetically different animals. Histochem J 2000;32:349-356.
24. Marvulli D, Volpin D, Bressan GM. Spatial and temporal changes of type VI collagen expression during mouse development. Dev Dyn 1996;206:447-454.
25. Myers JC, Dion AS, Abraham V, Amenta PS. Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones. Cell Tissue Res 1996; 286:493-505.
26. Nishimura T, Ojima K, Hattori A, Takahashi K. Developmental expression of extracellular matrix components in intramuscular connective tissue of bovine semitendinosus muscle. Histochem Cell Biol 1997;107:215-221.
27. Bailey AJ, Restall DJ, Sims TJ, Duance VC. Meat tenderness-immu-nofluorescent localization of the isomorphic forms of collagen in bovine muscles of varying texture. J Sci Food Agric 1979;30: 203-210.
28. Light N, Champion AE. Characterization of muscle epimysium, perimysium and endomysium collagens. Biochem J 1984;219: 1017-1026.
29. Fitch JM, Gross J, Mayne R, Johnson-Wint B, Linsenmayer TF. Organization of collagen types I and V in the embryonic chicken cornea: monoclonal antibody studies. Proc Natl Acad Sci USA 1984;81: 2791-2795.
30. Sanes JR. Laminin, fibronectin, and collagen in synaptic and extra-synaptic portions of muscle fiber basement membrane. J Cell Biol 1982;93:442-451.
31. Eklund L, Piuhola J, Komulainen J, Sormunen R, Ongvarrasopone C, Fassler R, et al. Lack of type XV collagen causes a skeletal myop-athy and cardiovascular defects in mice. Proc Natl Acad Sci USA 2001;98:1194-1199.
32. Grounds MD, Sorokin L, White J. Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 2005;15:381-391.
33. Brandan E, Inestrosa NC. Isolation of the heparan sulfate proteo-glycans from the extracellular matrix of rat skeletal muscle. J Neu-robiol 1987;18:271-282.
34. Mundhenke C, Meyer K, Drew S, Friedl A. Heparan sulfate proteo-glycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 2002;160:185-194.
35. Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 2001;108:349-355.
36. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta 1 release. Biochem J 1997;322:809-814.
37. Ishai-Michaeli R, Eldor A, Vlodavsky I. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul 1990;1:833-842.
38. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996;271:10079-10086.
39. Hedbom E, Heinegard D. Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem 1993;268: 27307-27312.
40. Pringle GA, Dodd CM. Immunoelectron microscopic localization of the core protein of decorin near the D-bands and E-bands of tendon collagen fibrils by use of monoclonal-antibodies. J Histochem Cytochem 1990;38:1405-1411.
41. Scott JE, Haigh M. 'Small'-proteoglycan:collagen interactions: kera-tan sulphate proteoglycan associates with rabbit corneal collagen fibrils at the 'a' and 'c' bands. Biosci Rep 1985;5:765-774.
42. Nakano T, Li X, Sunwoo HH, Sim JS. Immunohistochemical localization of proteoglycans in bovine skeletal muscle and adipose connective tissues. Can J Anim Sci 1997;77:169-172.
43. Scott JE. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry 1996;35: 8795-8799.
44. Weber IT, Harrison RW, Iozzo RV. Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 1996;271: 31767-31770.
45. Svensson L, Heinegard D, Oldberg A. Decorin-binding sites for collagen type-I are mainly located in leucine-rich repeats 4-5. J Biol Chem 1995;270:20712-20716.
46. Vogel KG, Koob TJ, Fisher LW. Characterization and interactions of a fragment of the core protein of the small proteoglycan (PGII) from bovine tendon. Biochem Biophys Res Commun 1987;148: 658-663.
47. Schonherr E, Witschprehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type-I collagen. J Biol Chem 1995;270:2776-2783.
48. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136: 729-743.
49. Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, et al. Phe-notypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 2002;17:1180-1189.
50. Mercado ML, Amenta AR, Hagiwara H, Rafii MS, Lechner BE, Owens RT, et al. Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J 2006; 20:1724-1726.
51. Ameye L, Young MF. Mice deficient in small leucine-rich proteogly-cans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers- Danlos syndrome, muscular dystrophy, and corneal diseases. Glyco-biology 2002;12:107R-116R.
52. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823.
53. von der Mark H, Durr J, Sonnenberg A, von der Mark K, Deutz-mann R, Goodman SL. Skeletal myoblasts utilize a novel beta 1-se-ries integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin. J Biol Chem 1991;266:23593-23601.
54. Wu C, Keivens VM, O'Toole TE, McDonald JA, Ginsberg MH. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995;83:715-724.
55. Rao CN, Margulies IM, Liotta LA. Binding domain for laminin on type IV collagen. Biochem Biophys Res Commun 1985;128:45-52.
56. Charonis AS, Tsilibary EC, Yurchenco PD, Furthmayr H. Binding of laminin to type IV collagen: a morphological study. J Cell Biol 1985;100:1848-1853.
57. Laurie GW, Bing JT, Kleinman HK, Hassell JR, Aumailley M, Martin GR, et al. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV) collagen. J Mol Biol 1986;189:205-216.
58. Mayer U, Nischt R, Poschl E, Mann K, Fukuda K, Gerl M, et al. A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J 1993;12:1879-1885.
59. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, et al. Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 1991;10:3137-3146.
60. Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 2003;278:12601-12604.
61. Ervasti JM. Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 2003;278:13591-13594.
62. Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, Pagel CN. Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro. Int J Biochem Cell Biol 2008;40:2303-2314.
63. Bradshaw AD. The role of SPARC in extracellular matrix assembly. J Cell Commun Signal 2009;3:239-246.
64. Malek MH, Olfert IM. Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp Physiol 2009;94:749-760.
65. Chiquet M, Fambrough DM. Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disul-fide-linked subunits. J Cell Biol 1984;98:1937-1946.
66. Cotman SL, Halfter W, Cole GJ. Identification of extracellular matrix ligands for the heparan sulfate proteoglycan agrin. Exp Cell Res 1999;249:54-64.
67. Chung CY, Erickson HP. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenas-cin-C. J Cell Sci 1997;110:1413-1419.
68. Cifuentes-Diaz C, Faille L, Goudou D, Schachner M, Rieger F, Angaut-Petit D. Abnormal reinnervation of skeletal muscle in a tenascin-C-deficient mouse. J Neurosci Res 2002;67:93-99.
69. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Ver-diere-Sahuque M, et al. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 1999;205:158-170.
70. Singh A, Nelson-Moon ZL, Thomas GJ, Hunt NP, Lewis MP. Identification of matrix metalloproteinases and their tissue inhibitors type 1 and 2 in human masseter muscle. Arch Oral Biol 2000;45: 431-440.
71. Wu N, Jansen ED, Davidson JM. Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing. J Invest Dermatol 2003;121: 926-932.
72. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272: 2446-2451.
73. Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 1997;124: 1519-1530.
74. Granzier H, Labeit S. Structure-function relations of the giant elastic protein titin in striated and smooth muscle cells. Muscle Nerve 2007;36:740-755.
75. Magid A, Law DJ. Myofibrils bear most of the resting tension in frog skeletal muscle. Science 1985;230:1280-1282.
76. Prado LG, Makarenko I, Andresen C, Kruger M, Opitz CA, Linke WA. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. J Gen Phys-iol 2005;126:461-480.
77. Ward SR, Tomiya A, Regev GJ, Thacker BE, Benzl RC, Kim CW, et al. Passive mechanical properties of the lumbar multifidus muscle support its role as a stabilizer. J Biomech 2009;42:1384-1389.
78. Lieber RL, Runesson E, Einarsson F, Friden J. Inferior mechanical properties of spastic muscle bundles due to hypertrophic but compromised extracellular matrix material. Muscle Nerve 2003;28: 464-471.
79. Meyer GA, Lieber RL. Elucidation of extracellular matrix mechanics from muscle fibers and fiber bundles. J Biomech 2011;44: 771-773.
80. Winters TM, Takahashi M, Lieber RL, Ward SR. Nonlinear scaling of passive tension in skeletal muscle. In: Workshop on Multi-Scale Muscle Mechanics, September 2009, Woods Hole, MA. p. 38.
81. Gillies A, Smith LR, Lieber RL, Varghese S. Method for decellula-rizing skeletal muscle without detergents or proteolytic enzymes. Tissue Eng Part C Methods 2011;17:383-389.
82. Ohtani O, Ushiki T, Taguchi T, Kikuta A. Collagen fibrillar networks as skeletal frameworks: a demonstration by cell-maceration/ scanning electron microscope method. Arch Histol Cytol 1988;51: 249-261.
83. Schenke-Layland K, Vasilevski O, Opitz F, Konig K, Riemann I, Halbhuber KJ, et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J Struct Biol 2003;143:201-208.
84. Stern MM, Myers RL, Hammam N, Stern KA, Eberli D, Kritchevsky SB, et al. The influence of extracellular matrix derived from skeletal muscle tissue on the proliferation and differentiation of myogenic progenitor cells ex vivo. Biomaterials 2009;30: 2393-2399.
85. Cosgrove BD, Sacco A, Gilbert PM, Blau HM. A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation 2009;78:185-194.
86. Péault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15:867-877.
87. Reist NE, Magill C, McMahan UJ. Agrin-like molecules at synaptic sites in normal, denervated, and damaged skeletal muscles. J Cell Biol 1987;105:2457-2469.
88. Cornbrooks CJ, Carey DJ, McDonald JA, Timpl R, Bunge RP. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci USA 1983;80:3850-3854.
89. Bunge MB, Williams AK, Wood PM, Uitto J, Jeffrey JJ. Comparison of nerve cell and nerve cell plus Schwann cell cultures, with particular emphasis on basal lamina and collagen formation. J Cell Biol 1980;84:184-202.
90. Archile-Contreras AC, Mandell IB, Purslow PP. Phenotypic differences in matrix metalloproteinase 2 activity between fibroblasts from three bovine muscles. J Anim Sci 2010;88:4006-4015.
91. Gatchalian CL, Schachner M, Sanes JR. Fibroblasts that proliferate near denervated synaptic sites in skeletal muscle synthesize the adhesive molecules tenascin(J1), N-CAM, fibronectin, and a heparan sulfate proteoglycan. J Cell Biol 1989;108:1873-1890.
92. Kuhl U, Ocalan M, Timpl R, Mayne R, Hay E, von der Mark K. Role of muscle fibroblasts in the deposition of type-IV collagen in the basal lamina of myotubes. Differentiation 1984;28:164-172.
93. Guerin CW, Holland PC. Synthesis and secretion of matrix-degrading metalloproteases by human skeletal muscle satellite cells. Dev Dyn 1995;202:91-99.
94. Beach RL, Rao JS, Festoff BW. Extracellular-matrix synthesis by skeletal muscle in culture. Major secreted collagenous proteins of clo-nal myoblasts. Biochem J 1985;225:619-627.
95. Brandan E, Fuentes ME, Andrade W. The proteoglycan decorin is synthesized and secreted by differentiated myotubes. Eur J Cell Biol 1991;55:209-216.
96. Sasse J, von der Mark H, Kuhl U, Dessau W, von der Mark K. Origin of collagen types I, III, and V in cultures of avian skeletal muscle. Dev Biol 1981;83:79-89.
97. Kuhl U, Timpl R, von der Mark K. Synthesis of type IV collagen and laminin in cultures of skeletal muscle cells and their assembly on the surface of myotubes. Dev Biol 1982;93:344-354.
98. Chiquet M, Gelman L, Lutz R, Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Bio-phys Acta 2009;1793:911-920.
99. Kusner LL, Young A, Tjoe S, Leahy P, Kaminski HJ. Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibers. Invest Ophthalmol Vis Sci 2010;51:192-200.
100. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-689.
101. Alexakis C, Partridge T, Bou-Gharios G. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 2007;293: C661-C669.
102. Alnaqeeb MA, Alzaid NS, Goldspink G. Connective tissue changes and physical properties of developing and ageing skeletal muscle. J Anat 1984;139:677-689.
103. Berria R, Wang L, Richardson DK, Finlayson J, Belfort R, Pratipana-watr T, et al. Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab 2006;290:E560-E565.
104. Duance VC, Stephens HR, Dunn M, Bailey AJ, Dubowitz V. A role for collagen in the pathogenesis of muscular dystrophy? Nature 1980;284:470-472.
105. Williams PE, Goldspink G. Connective tissue changes in immobilised muscle. J Anat 1984;138:343-350.
106. Florin L, Alter H, Grone HJ, Szabowski A, Schutz G, Angel P. Cre recombinase-mediated gene targeting of mesenchymal cells. Genesis 2004;38:139-144.
107. Fu Q, Schoenhoff FS, Savage WJ, Zhang P, van Eyk JE. Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl 2010;4:271-284.
108. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004;18:816-827.
109. Border WA, Noble NA. Transforming growth factor beta in tissue fi-brosis. N Engl J Med 1994;331:1286-1292.
110. Fadic R, Mezzano V, Alvarez K, Cabrera D, Holmgren J, Brandan E. Increase in decorin and biglycan in Duchenne muscular dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med 2006;10:758-769.
111. Zanotti S, Negri T, Cappelletti C, Bernasconi P, Canioni E, Di Blasi C, et al. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain 2005;128:2546-2555.
112. Zanotti S, Saredi S, Ruggieri A, Fabbri M, Blasevich F, Romaggi S, et al. Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes. Matrix Biol 2007;26:615-624.
113. Blalock TD, Duncan MR, Varela JC, Goldstein MH, Tuli SS, Groten-dorst GR, et al. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci 2003;44: 1879-1887.
114. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang XF, et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: downregula-tion by cAMP. FASEB J 1999;13:1774-1786.
115. Maeda N, Kanda F, Okuda S, Ishihara H, Chihara K. Transforming growth factor-beta enhances connective tissue growth factor expression in L6 rat skeletal myotubes. Neuromuscul Disord 2005;15: 790-793.
116. Mezzano V, Cabrera D, Vial C, Brandan E. Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2. J Cell Commun Signal 2007;1:205-217.
117. Schild C, Trueb B. Mechanical stress is required for high-level expression of connective tissue growth factor. Exp Cell Res 2002; 274:83-91.
118. Kivela R, Kyrolainen H, Selanne H, Komi PV, Kainulainen H, Vihko V. A single bout of exercise with high mechanical loading induces the expression of Cyr61/CCN1 and CTGF/CCN2 in human skeletal muscle. J Appl Physiol 2007;103:1395-1401.
119. Smith LR, Lee KS, Ward SR, Chambers HG, Lieber RL. Hamstring contractures in children with spastic cerebral palsy result from a stiffer ECM and increased in vivo sarcomere length. J Physiol (in press).
120. Friden J, Lieber RL. Spastic muscle cells are shorter and stiffer than normal cells. Muscle Nerve 2003;27:157-164.
121. Booth CM, Cortina-Borja MJ, Theologis TN. Collagen accumulation in muscles of children with cerebral palsy and correlation with severity of spasticity. Dev Med Child Neurol 2001;43:314-320.
122. Smith LR, Ponten E, Hedstrom Y, Ward SR, Chambers HG, Subra-maniam S, et al. Novel transcriptional profile in wrist muscles from cerebral palsy patients. BMC Med Genomics 2009;2:44.
123. Meyer GA, McCulloch AD, Ward SR, Lieber RL. Intermediate filament and ECM mechanics deduced from desmin knockout muscles. In: Biophysical Society 54th annual meeting, February 2010, San Francisco, CA. p 545a.
124. Chan YS, Li Y, Foster W, Fu FH, Huard J. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury. Am J Sports Med 2005;33:43-51.
125. Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J. The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med 2001;29:394-402.
126. Sato K, Li Y, Foster W, Fukushima K, Badlani N, Adachi N, et al. Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 2003;28: 365-372.
127. Schenk S, Horowitz JF. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 2007;117:1690-1698.
128. Leroy-Willig A, Willig TN, Henry-Feugeas MC, Frouin V, Marinier E, Boulier A, et al. Body composition determined with MR in patients with Duchenne muscular dystrophy, spinal muscular atrophy, and normal subjects. Magn Reson Imaging 1997;15:737-744.
129. Goodpaster BH, Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr Diabetes 2004;5: 219-226.
130. Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005;60: 324-333.
131. Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res 1994:78-83.
132. Nakagaki K, Ozaki J, Tomita Y, Tamai S. Fatty degeneration in the supraspinatus muscle after rotator cuff tear. J Shoulder Elbow Surg 1996;5:194-200.
133. Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, De Cuyper HJ. CT imaging of trunk muscles in chronic low back pain patients and healthy control subjects. Eur Spine J 2000;9: 266-272.
134. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multi-potential stem cells that exhibit myogenic, osteogenic, and adipo-genic differentiation. Differentiation 2001;68:245-253.
135. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K. Mesen-chymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010;12:143-152.
136. Uezumi A, Ojima K, Fukada S, Ikemoto M, Masuda S, Miyagoe-Suzuki Y, et al. Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun 2006;341:864-873.
137. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002;51:144-151.